Short bowel syndrome


Cite item

Full Text

Abstract

The paper gives information on the classification, pathogenesis, and clinical manifestations of short bowel syndrome following after intestinal resection. It discusses the treatment and rehabilitation of patients with this condition.

About the authors

A I Parfenov

ГБУЗ Москвы «Московский клинический научно-практический центр им. А.С. Логинова» Департамента здравоохранения Москвы

Москва, Россия

E A Sabelnikova

ГБУЗ Москвы «Московский клинический научно-практический центр им. А.С. Логинова» Департамента здравоохранения Москвы

Москва, Россия

T N Kuzmina

ГБУЗ Москвы «Московский клинический научно-практический центр им. А.С. Логинова» Департамента здравоохранения Москвы

Москва, Россия

References

  1. Pironi L, Arends J, Baxter J et al. ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults. Clin Nutr. 2015;34(2):171-80. 10.1016/j.clnu.2014.08.017
  2. Gillard L, Mayeur C, Robert V et al. Microbiota Is Involved in Post-resection Adaptation in Humans with Short Bowel Syndrome. Front Physiol. 2017;8:224. 10.3389/fphys.2017.00224
  3. Nightingale JMD, Woodward JM; Small Bowel and Nutrition Committee of the British Society of Gastroenterology. Guidelines for management of patients with a short bowel. Gut. 2006;55(Suppl.4):1-12. https://doi.org/10.1136/gut.2006.091108
  4. Парфенов А.И. Энтерология. 2-изд. М.: ООО «Медицинское информационное агентство», 2009. 880 с.
  5. Jeppesen PB. The novel use of peptide analogs in short bowel syndrome. Expert Rev. Gastroenterol. Hepatol. 2013;7(3):197-199. https://doi.org/10.1586/egh.13.2
  6. Suri M,Turner JM, Sigalet DL et al. Exogenous glucagon-like peptide-2 improves outcomes of intestinal adaptation in a distal-intestinal resection neonatal piglet model of short bowel syndrome. Pediatr Res. 2014;76(4):370-377. https://doi.org/10.1038/pr.2014.97
  7. Ардатская М.Д. Синдром избыточного бактериального роста и нарушение процессов пищеварения и всасывания: патогенетическая нутриционная терапия. Экспериментальная и клиническая гастроэнтерология. 2009;6:84-96.
  8. Tappenden K.A. Intestinal adaptation following resection. JPEN J Parenter Enteral Nutr. 2014;38(1,Suppl):23S-31S. https://doi.org/10.1177/0148607114525210
  9. López VR, Moreno AM, Boluda RE et al. Plasma citrulline concentration as a biomarker of intestinal function in short bowel syndrome and in intestinal transplant. An Pediatr (Barc). 2013;79(4):218-223. https://doi.org/10.1016/j.anpedi.2013.02.007
  10. Diamanti A, Panetta F, Gandullia P. et al. Plasma citrulline as marker of bowel adaptation in children with short bowel syndrome. Langenbeck’s archives of surgery. Deutsche Gesellschaft fur Chirurgie. 2011;396:1041-1046. https://doi.org/10.1007/s00423-011-0813-8
  11. Парфенов А.И., Бондаренко В.М. Что нам дал вековой опыт познания симбионтной кишечной микрофлоры (передовая статья) Терапевтический архив. 2012;83(2):5-10.
  12. De Castro Furtado E, Marchini JS, Kobori da Fonsesa C. et al. Cyclic parenteral nutrition does not change the intestinal microbiota in patients with short bowel syndrome. Acta Cirurgica Brasileira. 2013;28(1)26-31. https://doi.org/10.1590/s0102-86502013001300006
  13. Аmerican Gastroenterological Association medical position statement: Short bowel syndrome and intestinal transplantation. Gastroenterology 2003;124(4):1105-1110. https://doi.org/10.1053/gast.2003.50139
  14. Dibb M, Teubner A, Theis V, Shaffer J, Lal S. Review article: The management of long-term parenteral nutrition. Aliment. Pharmacol. Ther. 2013;37:587-603. https://doi.org/10.1111/apt.12209
  15. Pironi L, Arends J, Bozzetti F et al. Espen guidelines on chronic intestinal failure in adults. Spencer AU Clin. Nutr. 2016;35:247-307. https://doi.org/10.1016/j.clnu.2016.01.020
  16. Kowlgi NG, Chhabra L. D-lactic acidosis: an underrecognized complication of short bowel syndrome. Gastroenterol Res Pract. 2015:1-8. https://doi.org/10.1155/2015/476215
  17. Joly F, Dray X, Corcos O, Barbot L, Kapel N, Messing B. Tube Feeding Improves Intestinal Absorption in Short Bowel Syndrome Patients. J Gastroenterology. 2009;136:824-831. https://doi.org/10.1053/j.gastro.2008.10.084
  18. Sahin P, Molnár A, Varga M et al. Clinical nutrition therapy in patients with short bowel syndrome in line with principles of personalized medicine. Orv Hetil. 2014;155(51):2054-2062. https://doi.org/10.1556/oh.2014.29973
  19. Yildiz B. Where are we at with short bowel syndrome and small bowel transplant. World J Transplant. 2012;2(6):95-103. https://doi.org/10.5500/wjt.v2.i6.95
  20. Ming-Yi Liu, Hsiu-Chih Tang, Hui-Lan Yang et al. A Short Bowel (Small intestine = 40 cm), no ileocecal valve, and colonic inertia patient works well with oral intake alone without parenteral nutrition. Case Rep Surg. 2014;2014:1-3. https://doi.org/10.1155/2014/387307
  21. Cai J, Wu G, Qing A, et al. Organ Procurement and Transplantation Network/Scientific Registry of Transplant Recipients 2014 Data Report: Intestine. Clin Transpl. 2014:33-47. https://www.ncbi.nlm.nih.gov/pubmed/26281125
  22. Готье С.В., Цирульникова О.М., Ким Э.Ф. и соавт. Трансплантация тонкой кишки: первое наблюдение в России. Вестник трансплантологии и искусственных органов. 2006;4:19-23.
  23. Kubal C, Mangus R, Saxena R, et al. Prospective Monitoring of Donor-specific Anti-HLA antibodies after intestine/multivisceral transplantation: Significance of De Novo Antibodies. Transplantation 2015;99:49-56. https://doi.org/10.1097/tp.0000000000000614
  24. Hibi T, Nishida S, Garcia J, et al. Citrulline level is a potent indicator of acute rejection in the long term following pediatric intestinal/multivisceral transplantation. Am J Transplant 2012;12:S27-32. https://doi.org/10.1111/j.1600-6143.2012.04155.x
  25. Sudan D, Vargas L, Sun Y, et al. Calprotectin: a novel noninvasive marker for intestinal allograft monitoring. Ann Surg. 2007;246:311-315. https://doi.org/10.1097/sla.0b013e3180f61af4
  26. O’Keefe SJ, El Hajj II, Wu T, et al. Endoscopic Evaluation of Small Intestine Transplant Grafts. Transplantation. 2012;94:757-762. https://doi.org/10.1097/tp.0b013e31825f4410
  27. Doğan S.M., Kılınç S,Kebapçı E et al. Mesenchymal stem cell therapy in patients with small bowel transplantation: single center experience. World J Gastroenterol. 2014;20(25):8215-8220. https://doi.org/10.3748/wjg.v20.i25.8215
  28. Bharadwaj S, Tandon P, Gohel TD et al. Current status of intestinal and multivisceral transplantation. Gastroenterol Rep (Oxf). 2017;5(1):20-28. https://doi.org/10.1093/gastro/gow045
  29. Fryer JP and Iyer K. Innovative approaches to improving organ availability for small bowel transplant candidates. J Gastroenterology. 2006;130:152-157. https://doi.org/10.1053/j.gastro.2005.10.064

Copyright (c) 2017 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies